Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10312949Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$723.6K
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#22,519
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Christopher James Clarke as a PI. Multi-PI records show the full award amount for context.
- 5R01CA248080-05R01Neutral sphingomyelinase-2 as a mediator of Doxorubicin-induced cardiotoxicity$361.8Kaward amount
- 5R01CA248014-05R01Dihydroceramide desaturase (DES1) as a mediator of receptor tyrosine kinase-driven metastasis in breast cancer$361.8Kaward amount
Award organization
Organizations that administered FY2025 awards listing Christopher James Clarke as a PI.
FY2025 award administered by Stony Brook University (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardStony Brook University
- 2024$500K Cumulative Funding
- 2024R01 Grant Holder
- 2025$1M Cumulative Funding